(Reuters) – Biogen Inc said on Monday its research chief Alfred Sandrock, who led development of its Alzheimer’s disease drug Aduhelm, is leaving the company after a 23-year run.
Gypsum Board, Ceiling and Wrought Iron Works
(Reuters) – Biogen Inc said on Monday its research chief Alfred Sandrock, who led development of its Alzheimer’s disease drug Aduhelm, is leaving the company after a 23-year run.